SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-21-002513
Filing Date
2021-04-15
Accepted
2021-04-15 17:00:19
Documents
13
Period of Report
2021-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_041521.htm 6-K 12012
2 EXHIBIT 99.1 exh_991.htm EX-99.1 17848
3 GRAPHIC exh991_01.jpg GRAPHIC 176854
4 GRAPHIC exh991_02.jpg GRAPHIC 355816
5 GRAPHIC exh991_03.jpg GRAPHIC 148993
6 GRAPHIC exh991_04.jpg GRAPHIC 211070
7 GRAPHIC exh991_05.jpg GRAPHIC 273428
8 GRAPHIC exh991_06.jpg GRAPHIC 252890
9 GRAPHIC exh991_07.jpg GRAPHIC 180501
10 GRAPHIC exh991_08.jpg GRAPHIC 162529
11 GRAPHIC exh991_09.jpg GRAPHIC 182707
12 GRAPHIC exh991_10.jpg GRAPHIC 93658
13 GRAPHIC exh991_11.jpg GRAPHIC 205632
  Complete submission text file 0001171843-21-002513.txt   3120949
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36686 | Film No.: 21829162
SIC: 2834 Pharmaceutical Preparations